For more detail about the 2012 survey, see the Survey Methodology section of that years report
4 "The results of ACHIEVE-3 highlight the potential advantages of orforglipron over oral semaglutide for type 2 diabetes: greater A1C reduction, more weight loss, and the ability to take it without food or water timing restrictions that's a combination that could matter significantly to people managing their disease day in and day out," said Kenneth Custer, Ph.D., executive vice president and president of Lilly Cardiometabolic Health
Here are some factors to consider: Purity and Dosage: Look for supplements with a high concentration of active CLA, typically derived from safflower oil, and ensure the dosage matches clinical recommendations (usually 36 grams per day)
Currently, it is in Phase 3 clinical trials
Look out for additional symptoms that might accompany your tiredness